Clinical Trial

Use of Cinnamomum Verum for Induction of Labor. Double Blind Randomized Clinical Trial

Study acronym: CINNALAB
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The purpose of the research protocol is to evaluate the effectiveness of Cinnamomum verum extract for the initiation of labor. Cinnamaldehyde ((E)-3-Phenylprop-2-enal) is an α, β unsaturated aromatic aldehyde, derived from cinnamon (Cinnamomum Verum oil) used as a flavoring; It is a clear yellowish liquid substance, with a strong odor and flavor. It is the main component of cinnamon (63%), giving it its physicochemical properties. Cinnamon has been an element of empirical use for the beginning of labor, however, its effectiveness has not been demonstrated. Cinnamon has been reported for its ethnopharmacological properties in pregnancy, being used to facilitate childbirth, as a lactagogue and for postpartum recovery. In Honduras, its use has been reported to relieve nausea and vomiting during pregnancy, to reduce abdominal pain. , reduction of lower limb edema, to relieve anxiety during labor, as well as a lactagogue without convergent opinions.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2023-12-01; most recent amendment 2025-11-26.
Trial Details
NCT Number NCT06164613
Lead Sponsor Universidad Nacional Autonoma de Honduras
Conditions Labor Onset and Length Abnormalities, First Birth
Enrollment 70 participants
Start Date 2023-12-04
Primary Completion 2026-12-30 (estimated)
Study Completion 2026-12-30 (estimated)
Updated on ClinicalTrials.gov 2025-12-04